EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased interleukin‐ 17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice

Jeng-Kai Jiang iD, Chi-Hung Lin iD, Ting-An Chang iD, Liang-Chuan Lo iD, Chien-Ping Lin iD, Ruey-Hwa Lu, Chih-Yung Yang iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Jeng-Kai Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Interleukin-17. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Veterans General Hospital, Ministry of Science and Technology, Taiwan, Department of Health, Taipei City Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Interleukin‐17 (IL‐17) is a pro‐inflammatory cytokine that plays a vital role in the promotion of tumorigenesis in various cancers, including colorectal cancer (CRC). Based on current evidence, IL‐17 binds to interleukin‐17 receptor A (IL‐17RA); however, the role of IL‐17RA has not been elucidated in previous studies on CRC. In this study, we explored the role of IL‐17RA in human CRC tissues and the progression of CRC in humans and mice.

Methods

The expressions of IL‐17RA and epithelial‐mesenchymal transition (EMT)‐related genes were examined in CRC cells and tissue samples by quantitative real‐time polymerase chain reaction. The role of IL‐17RA in pathogenesis and prognosis was evaluated using a Chi‐squared test, Kaplan–Meier analysis, univariate, and multivariate Cox regression analysis in 133 CRC patients. A tumor‐bearing mice model was executed to evaluate the role of IL‐17RA in tumor growth, vascularity and population of infiltrating immune cells.

Results

IL‐17RA expression was found to be significantly higher in CRC tissues than in adjacent normal tissues. The expression of IL‐17RA in Stage IV patients was significantly higher than that in Stages I and II patients. Patients with high IL‐17RA expression exhibited significantly worse overall and CRC‐specific survival than those with low IL‐17RA expression. Functional assessment suggested that the knockdown of IL‐17RA expression distinctly suppressed cellular proliferation, migration, invasion, and EMT‐related gene expression. In a tumor‐bearing mouse model, decreased IL‐17RA expression significantly repressed tumor growth and vascularity and reduced the population of regulatory T cells (Tregs) and myeloid‐derived suppressor cells (MDSCs).

Conclusion

Reduced IL‐17RA expression also suppressed cellular proliferation, migration, and invasion, and the expression of EMT genes. Knockdown of IL‐17RA inhibited tumor growth and vascularity and decreased the population of Tregs and MDSCs in mouse tumors. Overall, IL‐17RA expression was identified to be independently associated with the prognosis of patients with CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsInterleukin-17AnimalsHumansMiceCell Line, TumorCell MovementCell ProliferationCytokinesDisease Models, AnimalEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticPrognosisReceptors, Interleukin-17

Stichwörter der Autor:innen

colorectal cancerinterleukin-17 receptor Aprognosistumor growth

Substanzen

CytokinesInterleukin-17IL17RA protein, humanReceptors, Interleukin-17Il17ra protein, mouse

Autor:innen und Institutionen

  • School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
  • Cancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Pathology, Ren-Ai Branch, Taipei City Hospital, Taipei, Taiwan.

ORCID-Profile: Jeng-Kai Jiang, Chi-Hung Lin, Ting-An Chang, Liang-Chuan Lo, Chien-Ping Lin, Chih-Yung Yang

Förderung

  • Taipei Veterans General Hospital
  • Ministry of Science and Technology, Taiwan
  • Department of Health, Taipei City Government

Zitieren

APA

Jiang, J. K., Lin, C. H., Chang, T. A., Lo, L. C., Lin, C. P., Lu, R. H., & Yang, C. Y. (2024). Decreased interleukin‐ 17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice. Cancer Medicine. https://doi.org/10.1002/cam4.7059

Vancouver

Jiang JK, Lin CH, Chang TA, Lo LC, Lin CP, Lu RH, et al. Decreased interleukin‐ 17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice. Cancer Medicine. 2024. doi:10.1002/cam4.7059

BibTeX
@article{Jiang2024,
  author = {Jiang, Jeng-Kai and Lin, Chi-Hung and Chang, Ting-An and Lo, Liang-Chuan and Lin, Chien-Ping and Lu, Ruey-Hwa and Yang, Chih-Yung},
  title = {Decreased interleukin‐ 17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7059}
}
Kostenlos starten →